Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Antigen presentation and related immunological aspects of HIV-1 vaccines.

Steinman RM, Germain RN.

AIDS. 1998;12 Suppl A:S97-112. Review. No abstract available.

PMID:
9632991
2.

Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.

Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ.

Vaccine. 2001 Dec 12;20(5-6):813-25.

PMID:
11738745
3.

DNA vaccines against human immunodeficiency virus type 1.

Estcourt MJ, McMichael AJ, Hanke T.

Immunol Rev. 2004 Jun;199:144-55. Review.

PMID:
15233732
4.

Preventing AIDS but not HIV-1 infection with a DNA vaccine.

Shen X, Siliciano RF.

Science. 2000 Oct 20;290(5491):463-5.

PMID:
11183769
5.

AIDS vaccine shows promise after years of frustration.

Cohen J.

Science. 2001 Mar 2;291(5509):1686-8. No abstract available.

PMID:
11263450
6.

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, Miller J, McClure HM, McNicholl JM, Moss B, Robinson HL.

Science. 2001 Apr 6;292(5514):69-74.

7.

Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.

De Rose R, Chea S, Dale CJ, Reece J, Fernandez CS, Wilson KM, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Sullivan MT, Kent SJ.

Vaccine. 2005 Mar 14;23(16):1949-56.

PMID:
15734067
8.

DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques.

Cherpelis S, Jin X, Gettie A, Ho DD, Barnett SW, Shrivastava I, Stamatatos L.

Immunol Lett. 2001 Nov 1;79(1-2):47-55.

PMID:
11595289
9.

Protection from HIV infection or AIDS?

Miedema F, Meyaard L, Klein MR.

Science. 1993 Nov 12;262(5136):1074-6. No abstract available.

PMID:
8235627
10.

HIV/AIDS vaccines: 2007.

Robinson HL.

Clin Pharmacol Ther. 2007 Dec;82(6):686-93. Epub 2007 Oct 31. Review.

PMID:
17971817
11.

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA.

Nature. 2002 Jan 17;415(6869):331-5.

PMID:
11797011
12.

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.

Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM, Montefiori D, Roberts A, Buonocore L, Rose JK.

Cell. 2001 Sep 7;106(5):539-49.

13.

A strategy for prophylactic vaccination against HIV.

Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM.

Science. 1993 May 28;260(5112):1270-2. No abstract available.

PMID:
8098553
14.

Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys.

Barouch DH, Fu TM, Montefiori DC, Lewis MG, Shiver JW, Letvin NL.

Immunol Lett. 2001 Nov 1;79(1-2):57-61.

PMID:
11595290
15.

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.

Mascola JR, Lewis MG, VanCott TC, Stiegler G, Katinger H, Seaman M, Beaudry K, Barouch DH, Korioth-Schmitz B, Krivulka G, Sambor A, Welcher B, Douek DC, Montefiori DC, Shiver JW, Poignard P, Burton DR, Letvin NL.

J Virol. 2003 Oct;77(19):10348-56.

16.

AIDS vaccine development.

Lévy JP.

Science. 1998 May 8;280(5365):806-7. No abstract available.

PMID:
9599149
17.

CD8+ T-cells: are they sufficient to prevent, contain or eradicate HIV-1 infection?

Brown SA, Hurwitz JL, Zhan X, Doherty PC, Slobod KS.

Curr Drug Targets Infect Disord. 2005 Jun;5(2):113-9. Review.

PMID:
15975017
18.

Prime-boost strategies in DNA vaccines.

Dale CJ, Thomson S, De Rose R, Ranasinghe C, Medveczky CJ, Pamungkas J, Boyle DB, Ramshaw IA, Kent SJ.

Methods Mol Med. 2006;127:171-97. Review.

PMID:
16988455
19.

Prime-boost vaccination with HIV-1 Gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses.

Tritel M, Stoddard AM, Flynn BJ, Darrah PA, Wu CY, Wille U, Shah JA, Huang Y, Xu L, Betts MR, Nabel GJ, Seder RA.

J Immunol. 2003 Sep 1;171(5):2538-47.

20.

The critical role of CD4(+) T-cell help in immunity to HIV.

Heeney JL.

Vaccine. 2002 May 6;20(15):1961-3. Review.

PMID:
11983254

Supplemental Content

Support Center